Skip to main content
Figure 3 | Experimental Hematology & Oncology

Figure 3

From: Molecular monitoring of minimal residual disease in two patients with MLL-rearranged acute myeloid leukemia and haploidentical transplantation after relapse

Figure 3

Conditioning regimens for haploidentical transplantation. For logistical reasons the irradiation was applied either before or after the chemotherapy. Stem cells were infused on day 0 in both patients. The second patients received donor-derived NK cells on day +1. In the first patient, NK cells were withheld until day +55 because of concerns regarding graft-versus-host disease due to the relatively high CD3+ cell content.

Back to article page